2025-10394Notice

EndyMed's Zappy Skin Gadgets Face Import Ban Over Patents

Published Date: 6/9/2025

Notice

Summary

The U.S. International Trade Commission found that EndyMed’s skin treatment devices broke patent rules and is blocking their import without permission. EndyMed must stop selling certain products and pay bonds during a review period. The investigation continues for one more patent, with a new deadline set.

Analyzed Economic Effects

4 provisions identified: 0 benefits, 3 costs, 1 mixed.

Import Ban on Certain EndyMed Devices

The U.S. International Trade Commission issued a limited exclusion order that prohibits the unlicensed importation of certain dermatological treatment devices and components that infringe claims of U.S. Patent Nos. 9,480,836; 9,320,536; 9,775,774; and 10,869,812. If you import or distribute these EndyMed devices, those specific products may be blocked from entering the U.S.

Cease-and-Desist Orders Against EndyMed

The Commission issued cease and desist orders directing EndyMed Medical Ltd. (Israel), EndyMed Medical, Ltd. (New York), and EndyMed Medical, Inc. (New Jersey) to stop activity related to the infringing products. If you are one of these respondents or work with them, you must stop selling or otherwise engaging in the covered activity for the listed products.

High Bonds Required During Presidential Review

During the period of Presidential review, the Commission set a bond equal to 85% of the entered value for EndyMed Pure infringing products and 70% of the entered value for EndyMed Pro infringing products that are imported. If you import those products during Presidential review, you must post the specified bond percentages of the entered value.

Remand and Extended Review for One Patent

The Commission reversed the administrative law judge’s finding that claims 4, 6, and 7 of U.S. Patent No. 11,406,444 were indefinite, remanded the investigation on that patent back to the ALJ consistent with the Commission opinion, and extended the target date for completing the investigation for that patent. If you are a party to that portion of the investigation, the review will continue under the remand and take longer to finish.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
6/9/2025

Department and Agencies

Department
Independent Agency
Agency
International Trade Commission
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in